Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Kayne Anderson Energy Infrastructure Fund reports $2.8B net assets and $16.62 NAV per share as of April 30, 2026

Market News
01 May 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

Kayne Anderson Energy Infrastructure Fund, Inc. announced its unaudited financials as of April 30, 2026, reporting net assets of $2.8 billion and a net asset value (NAV) per share of $16.62. The fund's asset coverage ratio for senior securities was 676%, and total leverage coverage was 520%, indicating strong financial health. Its portfolio is heavily invested in midstream energy companies, which make up 94% of long-term investments. This update provides investors insight into the fund's financial position and investment focus in energy infrastructure.

More News

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom Industries reported a record first quarter with contract revenues up 56.1% to $1.965 billion and adjusted net income nearly doubling to $134.3 million. The company raised its full-year fiscal 2027 revenue outlook to $7.38-$7.65 billion, driven ...

Company Fundamentals
Bullish
20 minutes ago
BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog, part of Tilray Brands, is rolling out a major summer campaign across the UK tied to the global football tournament. The campaign features a "Win a Year of Beer" contest with special cans hidden in over 2.8 million packs at major retailers, p...

Market News
Bullish
20 minutes ago
Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics, a biopharmaceutical company specializing in next-generation T cell therapies, announced it will present at two upcoming investor conferences: William Blair’s Growth Stock Conference on June 2 and Jefferies Global Healthcare Conf...

Market News
Neutral
20 minutes ago
Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharmaceuticals announced Phase 1 results indicating their Hepatitis C treatment regimen, combining bemnifosbuvir and ruzasvir, has a low risk of drug-drug interactions with common medications like omeprazole and rosuvastatin. This supports easi...

Market News
Bullish
20 minutes ago
Law firm probes Capital One stock drop post-Discover acquisition, urges affected investors to seek compensation

Law firm probes Capital One stock drop post-Discover acquisition, urges affected investors to seek compensation

Girard Sharp LLP is investigating potential securities claims for former Discover investors who received Capital One shares after Capital One acquired Discover in May 2025. Since the merger, Capital One's stock price has declined, leading to possible...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App